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Background
Aldehyde dehydrogenase-2 (ALDH2) was characterized
as the main enzyme responsible for bioactivation of the
antianginal drug nitroglycerin (GTN). We have recently
shown that ALDH2 is mainly cytosolic in murine vascu-
lar tissue, challenging the general assumption that GTN
bioactivation takes place in the mitochondrial matrix of
vascular smooth muscle cells.
Objective
In the present study we investigated whether bioactivation
of GTN is affected by the subcellular localization of
ALDH2 using immortalized ALDH2-deficient aortic
smooth muscle cells with selective overexpression of the
enzyme in either cytosol or mitochondria. Furthermore we
investigated a potential correlation between the relaxation
potency of GTN and the distribution of ALDH2 in arterial
blood vessels from different species as well as the subcellu-
lar distribution of the enzyme in several murine organs.
Methods and results
Radio thin layer chromatography analysis showed that
cytosolic overexpression of ALDH2 led to denitration
rates up to 4 times higher than mitochondrial overexpres-
sion, suggesting a more efficient bioactivation by cytosolic
ALDH2. Interestingly, denitration rates of smooth muscle
cells were even higher in cells without functional mito-
chondria (Rho0 cells), suggesting possible adverse effects
of mitochondria on the bioactivity of GTN. Quantitative
immunoblotting revealed that ALDH2 is mainly cytosolic
in murine, rat, guinea-pig and rabbit aortas as well as in
porcine, bovine and human coronary arteries. A similar
expression pattern was found in several murine organs,
except liver. Cumulative concentration-response curves to
GTN established by vasorelaxation studies were biphasic
for aortas with more than 10% ALDH2 in mitochondria
(mouse and rabbit), strengthening the hypothesis that
mitochondrial GTN metabolism counteracts cytosolic
bioactivation of the drug.
Conclusions
The data indicate that cytosolic expression is essential for
GTN bioactivation in arterial blood vessels and aortic
smooth muscle cells, presumably due to limited access of
GTN to the mitochondrial matrix.
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